Aerovate Therapeutics (AVTE) News Today $7.38 +0.53 (+7.74%) As of 08/21/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVTE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Up 2.3% - Still a Buy?August 12, 2025 | marketbeat.comAerovate Therapeutics (AVTE) Expected to Announce Quarterly Earnings on MondayAugust 5, 2025 | marketbeat.comAerovate Therapeutics (NASDAQ:AVTE) Trading Up 7.9% - Still a Buy?July 19, 2025 | marketbeat.comDeltec Asset Management LLC Raises Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)June 21, 2025 | marketbeat.comMillennium Management LLC Cuts Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)June 13, 2025 | marketbeat.comTwo Sigma Investments LP Cuts Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)June 9, 2025 | marketbeat.comTwo Sigma Advisers LP Grows Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)June 5, 2025 | marketbeat.comBNP Paribas Financial Markets Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)June 1, 2025 | marketbeat.com600,000 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Purchased by Jefferies Financial Group Inc.May 30, 2025 | marketbeat.comJefferies Financial Group Inc. Makes New $1.59 Million Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)May 17, 2025 | marketbeat.com60,000 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Acquired by Bridgeway Capital Management LLCMay 16, 2025 | marketbeat.comRenaissance Technologies LLC Buys 26,700 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE)May 10, 2025 | marketbeat.comBraidwell LP Buys Shares of 1,440,499 Aerovate Therapeutics, Inc. (NASDAQ:AVTE)May 8, 2025 | marketbeat.comBlackstone Inc. Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)May 8, 2025 | marketbeat.comAerovate Therapeutics (AVTE) to Release Earnings on MondayMay 7, 2025 | marketbeat.comJPMorgan Chase & Co. Has $178,000 Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)May 6, 2025 | marketbeat.comAllostery Investments LP Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)May 4, 2025 | marketbeat.comInvestors Buy Large Volume of Call Options on Aerovate Therapeutics (NASDAQ:AVTE)April 30, 2025 | marketbeat.comNantahala Capital Management LLC Acquires New Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)April 30, 2025 | marketbeat.comAerovate Therapeutics, Inc. (NASDAQ:AVTE) to Issue Dividend of $2.40April 29, 2025 | marketbeat.comJade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 MillionApril 28, 2025 | globenewswire.comAerovate Stockholders Approve Merger Proposal With Jade BiosciencesApril 23, 2025 | nasdaq.comAerovate Therapeutics stockholders approve proposed merger with Jade BiosciencesApril 23, 2025 | markets.businessinsider.comAerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related ProposalsApril 21, 2025 | prnewswire.comAffinity Asset Advisors LLC Purchases 200,000 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE)April 17, 2025 | marketbeat.comAerovate Therapeutics declares special cash dividend, estimated $2.40 per shareApril 10, 2025 | markets.businessinsider.comAerovate Therapeutics sees $67.6M-$69.6M dividend in connection with JadeApril 9, 2025 | markets.businessinsider.comAerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade BiosciencesApril 9, 2025 | prnewswire.comAerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade BiosciencesApril 9, 2025 | prnewswire.comAerovate Therapeutics, Inc. (NASDAQ:AVTE) Shares Bought by ADAR1 Capital Management LLCApril 9, 2025 | marketbeat.comAerovate Therapeutics Stock Bucks Broader Market Sell-Off Over Dividend Announcement: Stock Rises But Retail’s UnmovedApril 7, 2025 | msn.comAerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade BiosciencesApril 7, 2025 | prnewswire.com$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of AMPY, HEES, AVTE, TGI to ActApril 3, 2025 | morningstar.comMAerovate Therapeutics (NASDAQ:AVTE) Issues Quarterly Earnings Results, Meets ExpectationsMarch 29, 2025 | marketbeat.comSTOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - NHHS, KVAC, AMPS, AVTEMarch 20, 2025 | morningstar.comM$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – NHHS, KVAC, AMPS, AVTEMarch 19, 2025 | morningstar.comMAnalysts Offer Predictions for AVTE FY2029 EarningsFebruary 26, 2025 | marketbeat.comAerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest UpdateFebruary 17, 2025 | marketbeat.comDeltec Asset Management LLC Acquires New Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)February 5, 2025 | marketbeat.comAerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Up 35.5% in JanuaryJanuary 30, 2025 | marketbeat.com$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - IPG, VTS, AVTE, MHLDJanuary 24, 2025 | markets.businessinsider.comJane Street Group LLC Trims Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE)January 17, 2025 | marketbeat.comUnusually active option classes on open January 16thJanuary 16, 2025 | markets.businessinsider.comStock Traders Buy High Volume of Aerovate Therapeutics Call Options (NASDAQ:AVTE)January 16, 2025 | marketbeat.comShort Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Rises By 35.5%January 16, 2025 | marketbeat.comAVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to ShareholdersDecember 28, 2024 | businesswire.comShort Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Decreases By 5.3%December 17, 2024 | marketbeat.comGSA Capital Partners LLP Purchases 287,163 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE)November 17, 2024 | marketbeat.comShort Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Declines By 17.3%November 15, 2024 | marketbeat.comWedbush Forecasts Higher Earnings for Aerovate TherapeuticsNovember 15, 2024 | marketbeat.com Get Aerovate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTE and its competitors with MarketBeat's FREE daily newsletter. Email Address AVTE Media Mentions By Week AVTE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVTE News Sentiment▼0.000.54▲Average Medical News Sentiment AVTE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVTE Articles This Week▼01▲AVTE Articles Average Week Get Aerovate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Immunome News Today Pharming Group News Today uniQure News Today Akebia Therapeutics News Today Anavex Life Sciences News Today Sana Biotechnology News Today atai Life Sciences News Today ArriVent BioPharma News Today Oculis News Today BGM Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVTE) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access